Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease

JAMA. 2005 May 18;293(19):2343-51. doi: 10.1001/jama.293.19.2343.

Abstract

Context: While gluten ingestion is responsible for the signs and symptoms of celiac disease, it is not known what factors are associated with initial appearance of the disease.

Objective: To examine whether the timing of gluten exposure in the infant diet was associated with the development of celiac disease autoimmunity (CDA).

Design, setting, and patients: Prospective observational study conducted in Denver, Colo, from 1994-2004 of 1560 children at increased risk for celiac disease or type 1 diabetes, as defined by possession of either HLA-DR3 or DR4 alleles, or having a first-degree relative with type 1 diabetes. The mean follow-up was 4.8 years.

Main outcome measure: Risk of CDA defined as being positive for tissue transglutaminase (tTG) autoantibody on 2 or more consecutive visits or being positive for tTG once and having a positive small bowel biopsy for celiac disease, by timing of introduction of gluten-containing foods into the diet.

Results: Fifty-one children developed CDA. Findings adjusted for HLA-DR3 status indicated that children exposed to foods containing wheat, barley, or rye (gluten-containing foods) in the first 3 months of life (3 [6%] CDA positive vs 40 [3%] CDA negative) had a 5-fold increased risk of CDA compared with children exposed to gluten-containing foods at 4 to 6 months (12 [23%] CDA positive vs 574 [38%] CDA negative) (hazard ratio [HR], 5.17; 95% confidence interval [CI], 1.44-18.57). Children not exposed to gluten until the seventh month or later (36 [71%] CDA positive vs 895 [59%] CDA negative) had a marginally increased risk of CDA compared with those exposed at 4 to 6 months (HR, 1.87; 95% CI, 0.97-3.60). After restricting our case group to only the 25 CDA-positive children who had biopsy-diagnosed celiac disease, initial exposure to wheat, barley, or rye in the first 3 months (3 [12%] CDA positive vs 40 [3%] CDA negative) or in the seventh month or later (19 [76%] CDA positive vs 912 [59%] CDA negative) significantly increased risk of CDA compared with exposure at 4 to 6 months (3 [12%] CDA positive vs 583 [38%] CDA negative) (HR, 22.97; 95% CI, 4.55-115.93; P = .001; and HR, 3.98; 95% CI, 1.18-13.46; P = .04, respectively).

Conclusion: Timing of introduction of gluten into the infant diet is associated with the appearance of CDA in children at increased risk for the disease.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Autoantibodies
  • Autoimmunity
  • Biopsy
  • Celiac Disease / diagnosis
  • Celiac Disease / epidemiology
  • Celiac Disease / immunology*
  • Child, Preschool
  • Diet*
  • Edible Grain*
  • Glutens / administration & dosage*
  • Humans
  • Infant
  • Intestine, Small / pathology
  • Prospective Studies
  • Risk Factors
  • Time Factors
  • Transglutaminases / immunology

Substances

  • Autoantibodies
  • Glutens
  • Transglutaminases